chr19-17268975-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_014173.4(BABAM1):āc.169A>Gā(p.Ser57Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000437 in 1,578,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 31)
Exomes š: 0.000045 ( 0 hom. )
Consequence
BABAM1
NM_014173.4 missense
NM_014173.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.77
Genes affected
BABAM1 (HGNC:25008): (BRISC and BRCA1 A complex member 1) Involved in several processes, including mitotic G2 DNA damage checkpoint signaling; positive regulation of DNA repair; and protein K63-linked deubiquitination. Located in cytosol and nuclear body. Part of BRCA1-A complex and BRISC complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity BABA1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.127226).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BABAM1 | NM_014173.4 | c.169A>G | p.Ser57Gly | missense_variant | 2/9 | ENST00000598188.6 | NP_054892.2 | |
BABAM1 | NM_001033549.3 | c.169A>G | p.Ser57Gly | missense_variant | 2/9 | NP_001028721.1 | ||
BABAM1 | NM_001288756.2 | c.169A>G | p.Ser57Gly | missense_variant | 2/9 | NP_001275685.1 | ||
BABAM1 | NM_001288757.2 | c.169A>G | p.Ser57Gly | missense_variant | 2/6 | NP_001275686.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BABAM1 | ENST00000598188.6 | c.169A>G | p.Ser57Gly | missense_variant | 2/9 | 1 | NM_014173.4 | ENSP00000471605 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152202Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
152202
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000261 AC: 5AN: 191590Hom.: 0 AF XY: 0.0000289 AC XY: 3AN XY: 103956
GnomAD3 exomes
AF:
AC:
5
AN:
191590
Hom.:
AF XY:
AC XY:
3
AN XY:
103956
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000449 AC: 64AN: 1425964Hom.: 0 Cov.: 31 AF XY: 0.0000425 AC XY: 30AN XY: 706394
GnomAD4 exome
AF:
AC:
64
AN:
1425964
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
706394
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74352
GnomAD4 genome
AF:
AC:
5
AN:
152202
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.169A>G (p.S57G) alteration is located in exon 2 (coding exon 1) of the BABAM1 gene. This alteration results from a A to G substitution at nucleotide position 169, causing the serine (S) at amino acid position 57 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T;.;T;T;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.;T;T;T;T;T;.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L;.;.;L;.;.;.;.;.
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Uncertain
.;D;D;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;T;D;D;T;D;D;T;D;D
Polyphen
B;.;B;.;.;B;.;.;.;.;.
Vest4
MVP
MPC
0.26
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at